Sign up to save your podcasts
Or
Share Multi-Refractory MM: Supporting the Patient Receiving a Novel T-Cell-Redirecting Bispecific Antibody
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Multi-Refractory MM: Supporting the Patient Receiving a Novel T-Cell-Redirecting Bispecific Antibody
AONN+ is pleased to present an exclusive podcast providing peer-to-peer nursing perspectives on the current role of immunotherapy in patients with advanced multiple myeloma (MM) and introducing a new class of agents: T-cell–redirecting bispecific antibodies (Tcr-bsAbs).
View all episodes
AONN+ is pleased to present an exclusive podcast providing peer-to-peer nursing perspectives on the current role of immunotherapy in patients with advanced multiple myeloma (MM) and introducing a new class of agents: T-cell–redirecting bispecific antibodies (Tcr-bsAbs).